XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-Based Compensation Expense

The table below sets forth the line items where share-based compensation expense was recorded for the twelve months ended December 31:

 

 

 

2021

 

 

2020

 

 

2019

 

Cost of goods sold

 

$

1,321

 

 

$

1,064

 

 

$

925

 

Selling, general and administrative expense

 

 

28,188

 

 

 

21,013

 

 

 

16,687

 

Research and development expense

 

 

3,696

 

 

 

3,183

 

 

 

2,923

 

Total share-based compensation expense

 

$

33,205

 

 

$

25,260

 

 

$

20,535

 

Schedule of Share-Based Compensation Expense by Type

The table below sets forth share-based compensation expense by type for the twelve months ended December 31:

 

 

 

2021

 

 

2020

 

 

2019

 

Stock options

 

$

73

 

 

$

-

 

 

$

-

 

Share grants

 

 

33,132

 

 

 

25,260

 

 

 

20,535

 

Total share-based compensation expense

 

$

33,205

 

 

$

25,260

 

 

$

20,535

 

Schedule of Share Based Compensation Stock Options Activity

The table below sets forth a summary of activity in our stock option plan:

Stock Options

 

Shares

 

 

Weighted Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual Term
(years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2018

 

 

988

 

 

 

23.47

 

 

 

 

 

$

8,693

 

Exercised

 

 

(524

)

 

 

22.68

 

 

 

 

 

$

10,600

 

Outstanding and Exercisable at December 31, 2019

 

 

464

 

 

 

24.37

 

 

 

 

 

$

14,849

 

Exercised

 

 

(272

)

 

 

25.11

 

 

 

 

 

$

8,278

 

Outstanding and Exercisable at December 31, 2020

 

 

192

 

 

 

23.32

 

 

 

 

 

$

9,059

 

Exercised

 

 

(187

)

 

 

23.19

 

 

 

 

 

$

10,631

 

Outstanding and Exercisable at December 31, 2021

 

 

5

 

 

 

27.92

 

 

 

0.4

 

 

$

409

 

Schedule of Stock Options Outstanding

The table below sets forth information about stock options outstanding at December 31, 2021:

 

Plan

 

Range of Exercise Prices

 

 

Number Exercisable

 

 

Weighted Average Remaining Contractual Life
 (Years)

 

 

Weighted Average Exercise Price

 

 2013 Plan

 

$

27.92

 

 

 

5,000

 

 

 

0.4

 

 

$

27.92

 

Summary of Nonvested Share Grants

The table below sets forth a summary of our non-vested share grants in 2020, 2019 and 2018:

Nonvested at December 31, 2018

 

 

1,667

 

 

 

26.68

 

 

 

 

Granted

 

 

670

 

 

 

38.15

 

 

 

 

Vested

 

 

(573

)

 

 

24.90

 

 

 

 

Forfeited

 

 

(67

)

 

 

30.44

 

 

 

 

Nonvested at December 31, 2019

 

 

1,697

 

 

 

31.71

 

 

 

 

Granted

 

 

573

 

 

 

48.83

 

 

 

 

Vested

 

 

(770

)

 

 

27.78

 

 

 

 

Forfeited and other

 

 

88

 

 

 

38.31

 

 

 

 

Nonvested at December 31, 2020

 

 

1,588

 

 

 

39.30

 

 

 

 

Granted

 

 

598

 

 

 

79.26

 

 

 

 

Vested

 

 

(750

)

 

 

33.39

 

 

$

60,346

 

Forfeited and other

 

 

(34

)

 

 

52.27

 

 

 

 

Nonvested at December 31, 2021

 

 

1,402

 

 

 

54.94

 

 

$

153,989